Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.

Source:http://linkedlifedata.com/resource/pubmed/id/1503909

Download in:

View as

General Info

PMID
1503909